HIMSS TV

In a preview of his HIMSS23 keynote, OpenEXO founder and chair Salim Ismail discusses the opportunities of "disruptive convergence," and describes some of its challenges.

The two-week program fuses technology and traditional therapy to treat PTSD and other conditions in post-9/11 vets. Barbara Rothbaum, executive director of the Emory Healthcare Veterans Program and Trauma and Anxiety Recovery Program, explains.

A sneak preview into a HIMSS23 panel on using machine learning to find discharge medication errors, featuring Kyle Longhurst, product manager at Pariveda, and Wendy Paul, medication process architect at Seattle Children's Hospital.

In a preview of her HIMSS23 session, Florence Hudson, executive director of Columbia University Northeast Big Data Innovation Hub, describes the Clinical Internet of Things, a new IEEE spec designed around trust, identity, privacy, protection and safety.

Previewing his HIMSS23 panel, Dr. Manish Kohli, board member of Wings of Hope and chief digital health officer and global head of humanitarian programs at Securra Health, explains how Wings of Hope uses tech to aid isolated communities.

Providence's senior manager of workforce optimization and innovation, Natalie Edgeworth, looks back and looks forward at AI in staffing optimization.

Matt Doyle, R&D Team Lead & Software Development Team Leader for Interoperability at Epic, highlights the benefits of healthcare interoperability and how as a QHIN the company will simplify connectivity for providers.

In a preview of his HIMSS23 presentation, Sidney Dixon, chief applications officer at Tower Health, discusses the value of properly archiving legacy data as part of EHR conversions.

ATSS Chief Operating Officer Sami Boustany discusses providing RPM systems to institutions such as the Saud Al-Babtain Cardiac Center and other ongoing work with the Saudi Ministry of Health.

Tom O'Neil, managing director of Berkeley Research Group, says boards need to think hard about how machine learning models are approved and deployed, since big issues related to safety, efficacy and transparency are at stake.